Friday 6 November 2026
Export THC’s income statement to Excel — free account
Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
283.11
3.35
−1.17%
Follow THC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 8 | 8 | 8 |
| 23.77% | 27.05% | 37.25% | 43.93% | ||
| 4.80% | 5.64% | 7.55% | 9.50% | ||
ROIC |
13.45% | 15.75% | 19.01% | 21.64% | |
Return on Tangible Assets |
14.50% | 20.14% | 26.31% | 30.84% | |
Average Days of Receivables |
43.93 | 44.32 | 43.64 | 42.75 | |
Free Cash Flow per Share |
28.06 | 38.58 | 36.19 | 41.53 | |
Free Cash Flow |
2,530.00 | 3,349.00 | 3,023.00 | 3,328.00 | |
Capital Expenditures |
(1,010.00) | (1,017.00) | (992.00) | (910.00) | |
| Other line items | |||||
Cash ROIC |
11.46% | 14.63% | 13.76% | 14.26% | |
Accounts Receivable Turnover |
8.36 | 8.21 | 8.49 | 8.67 | |
Accounts Payable Turnover |
9.41 | 9.45 | 9.31 | 9.29 | |
Inventory Turnover |
35.98 | 36.66 | 37.62 | 37.14 | |
Average Days of Payables |
39.76 | 38.81 | 39.35 | 39.74 | |
Days of Inventory on Hand |
10.17 | 9.94 | 9.70 | 9.74 | |
Tax Rate |
(0.15) | (0.16) | (0.18) | (0.19) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.49% | 0.50% | 0.61% | 0.58% | |
Interest Coverage |
4.27 | 5.20 | 6.54 | 7.62 | |
Operating CF/Net income |
2.52 | 2.56 | 1.79 | 1.46 | |
Depreciation/Fixed assets |
0.14 | 0.15 | 0.15 | 0.15 | |
Capex/Depreciation |
(1.14) | (1.12) | (1.08) | (1.00) | |
Revenue per Share |
236.38 | 247.17 | 261.15 | 276.46 | |
Operating CF per Share |
39.27 | 50.30 | 48.07 | 52.89 | |
Capex per Share |
(11.20) | (11.72) | (11.88) | (11.36) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.04 |
Columns are period end dates · fundamentals updated 2 Nov 2026